Accel Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,370
Closed -$89.1K 253
2023
Q1
$89.1K Hold
4,370
0.04% 357
2022
Q4
$92.7K Hold
4,370
0.04% 250
2022
Q3
$86K Hold
4,370
0.05% 269
2022
Q2
$92K Hold
4,370
0.05% 248
2022
Q1
$80K Hold
4,370
0.04% 284
2021
Q4
$78K Buy
+4,370
New +$74.2K 0.04% 303

Other funds holding BTAL

Accel Wealth Management's BTAL Position: Q2 2023 in Review

Accel Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 4,370 shares — an estimated $89.1K sold.

Accel Wealth Management first reported a position in BTAL in Q4 2021 and held it in 6 quarters. The position peaked at $92.7K in Q4 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Accel Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 4,370 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $89.1K.
  • Accel Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and held it in 6 quarters.
  • Accel Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $92.7K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.